For an elderly female hospice patient with opioid‑induced constipation, is a glycerin or bisacodyl suppository preferred over a Fleet (sodium phosphate) enema, or should another therapy be used to promote bowel movements?

Management of Opioid-Induced Constipation in an Elderly Hospice Patient

For an elderly female hospice patient with opioid-induced constipation, start with a bisacodyl suppository (10 mg) rather than a Fleet enema, and reserve enemas for refractory cases or fecal impaction. 1, 2

Rationale for Suppository Over Enema

Bisacodyl suppositories provide gentle, predictable, fast relief and are less invasive than enemas in the hospice setting. 1 The FDA-approved bisacodyl suppository (10 mg) is specifically designed as a stimulant laxative for rectal administration and represents a first-line rectal intervention. 1

Fleet (sodium phosphate) enemas carry specific risks in elderly hospice patients:

• Dehydration risk: If no liquid comes out of the rectum after 30 minutes, dehydration could occur, requiring prompt physician notification. 3
• Electrolyte disturbances: Sodium phosphate absorption can be problematic in frail elderly patients with renal impairment or dehydration. 3
• More invasive: Enemas require greater patient cooperation and positioning, which may compromise dignity and comfort in hospice care. 3

Algorithmic Approach to Rectal Interventions

Step 1: Assess for fecal impaction

• Perform digital rectal examination to identify hard stool in the rectal vault. 2
• If impaction is present, digital disimpaction with glycerin suppository should be performed first to enhance medication effectiveness. 2, 4

Step 2: Choose initial rectal therapy

• Bisacodyl suppository 10 mg is the preferred first-line rectal agent for opioid-induced constipation without impaction. 1, 2
• Glycerin suppositories are less effective as monotherapy but can be used adjunctively during disimpaction. 2

Step 3: Escalate if no response

• If bisacodyl suppository fails after 5 minutes and no urge to defecate occurs, consider a phosphate enema (Fleet) as second-line therapy. 3, 2
• Sodium citrate micro-enemas are an alternative to Fleet with potentially fewer electrolyte concerns. 5

Critical Hospice-Specific Considerations

Prophylactic oral laxatives should have been initiated when opioids were started. 6, 7 Opioids cause constipation in 40–80% of patients receiving chronic therapy, and up to 87% of terminally ill patients on opioids experience constipation. 6, 5 The fact that this patient now requires rectal intervention suggests inadequate prophylaxis.

The standard prophylactic regimen combines a stool softener with a stimulant laxative (e.g., sennoside plus docusate), though recent evidence questions docusate's efficacy. 2, 8 For ongoing management after this acute episode, ensure the patient receives:

• Senna (stimulant laxative) as the backbone of therapy. 8, 7
• Polyethylene glycol (osmotic laxative) if senna alone is insufficient. 8, 9

When to Consider Alternative Therapies

Peripherally acting μ-opioid receptor antagonists (PAMORAs) such as methylnaltrexone are highly effective for opioid-induced constipation refractory to laxatives, with response rates 3.83 times higher than placebo. 9 However, methylnaltrexone must be avoided if bowel obstruction is suspected. 7

Methylnaltrexone dosing is approximately 0.3 mg/kg IV or 12 mg subcutaneously and reverses opioid-induced constipation without diminishing central analgesia. 10 Despite proven efficacy, over 75% of hospice organizations report never using methylnaltrexone, likely due to cost and route of administration. 8

Common Pitfalls to Avoid

• Do not use Fleet enema as first-line rectal therapy in elderly hospice patients due to dehydration and electrolyte risks. 3
• Do not rely on docusate (stool softener) alone; it lacks robust evidence for treating established opioid-induced constipation and should always be combined with a stimulant laxative. 2, 8
• Do not overlook fecal impaction; attempting laxatives or suppositories without first removing impacted stool will fail. 2, 4
• Do not forget that opioid-induced constipation requires prophylaxis from day one of opioid therapy, not reactive treatment after constipation develops. 6, 7

Practical Implementation

For this patient right now:

1. Perform digital rectal exam to rule out impaction. 2
2. If impacted: Digital disimpaction with glycerin, then bisacodyl suppository. 2
3. If not impacted: Bisacodyl suppository 10 mg rectally. 1, 2
4. If bisacodyl fails: Fleet enema 4.5 fl oz (133 mL) as rescue, monitoring for dehydration. 3
5. Optimize oral regimen: Ensure senna ± polyethylene glycol is prescribed daily going forward. 8, 7, 9